The goal of this belief updating study is to assess the utility of BioEP as a complementary support tool in aiding clinical decision making in adults in first seizure clinics. The main outcomes we shall measure are: * Clinicians' perception of seizure probability. * Clinicians' decision to recommend commencing or deferring ASM (anti-seizure medications) * Clinicians' decision to refer for additional investigations/services. Participants will consent to have their EEG (that is taken at their routine care) to be used in the study. There is not extra burden to the participants taking part in the study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinicians' perception of seizure probability in a 2 step process, using a 7-category scale and a 100-mm visual analogue scale
Timeframe: 1 day
Number of additional patient's investigations/services
Timeframe: 1 year
Number of Clinicians' decisions to recommend commencing or deferring anti-seizure medications (ASM)
Timeframe: 1 year